Understanding Chronic Lymphocytic Leukemia
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
• Any low grade lymphoproliferative disorder
• Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
Locations
United States
Massachusetts
Dana Farber Cancer Institute
RECRUITING
Boston
Contact Information
Primary
Jennifer Brown, MD, PhD
Jennifer_brown@dfci.harvard.edu
617-582-8437
Time Frame
Start Date: 1999-09-29
Estimated Completion Date: 2032-09-29
Participants
Target number of participants: 2750
Treatments
Sample Collection
* Blood tests required for assessment~* Specimens and data will also be collected from outside sites~* Clinical data from patients with Chronic Lymphocytic Leukemia will be gathered into a database at Dana Farber Cancer Institute
Related Therapeutic Areas
Sponsors
Leads: Dana-Farber Cancer Institute
Collaborators: National Cancer Institute (NCI)